Skip Nav Destination
Progress and Challenges in Transfusion Medicine, Hemostasis, and Hemotherapy: State of the Art 200841st Congress of the German Society for Transfusion Medicine and Immunohematology, Düsseldorf, September 2008Available to Purchase
Edited by
S. Karger GmbH
Status:
Available
ISBN electronic:
978-3-8055-8660-3
ISBN print:
978-3-8055-8659-7
Publication date:
2008
Book Details
Modern transfusion medicine is sophisticated hemotherapy. Cellular and humoral blood components can be relevant in virtually every disease, either as a primary determinant in pathophysiology or as a victim of collateral damage, e.g. during treatment with cytostatic drugs, or as crucial substrates in replacement and hemostasis-navigated hemotherapy. With its interdisciplinary approach modern hemotherapy is a paragon of translational research bridging the bench-to-bedside gap in biomedicine. The state-of-the-art contributions collected here aim to stimulate lively discussions - not only among blood center professionals but also with blood and vascular biologists, hematologists, immunologists, anesthesiologists, intensive care specialists, surgeons, cardiologists, nephrologists, rheumatologists, and pulmonary and infectious disease specialists.
Progress and Challenges in Transfusion Medicine, Hemostasis, and Hemotherapy: State of the Art 200841st Congress of the German Society for Transfusion Medicine and Immunohematology, Düsseldorf, September 2008
Edited by: R.E. Scharf
https://doi.org/10.1159/isbn.978-3-8055-8660-3
ISBN (print): 978-3-8055-8659-7
ISBN (electronic): 978-3-8055-8660-3
Publisher: S. Karger GmbH
Published: 2008
Download citation file:
Digital Version
Pay-Per-View Access
$112.00
Print Version
Progress and Challenges in Transfusion Medicine, Hemostasis, and Hemotherapy
$112.00
Table of Contents
-
1 - 14: Increasing Safety by Implementing Optimized Team Interaction – Experiences of the Aviation IndustryByManfred H. MüllerManfred H. MüllerLufthansa Flight Safety Department, Frankfurt/Main, GermanySearch for other works by this author on:
-
15 - 23: Allogeneic Hematopoietic Cell Transplantation – 2008: Achievements and ChallengesByKarl G. BlumeKarl G. BlumeStanford University School of Medicine, Stanford, CA, USASearch for other works by this author on:
-
24 - 36: Endothelium and Hemostasis in Health and DiseaseByJan Steffel;Jan SteffelCardiology, CardioVascular Center, University Hospital Zurich and Cardiovascular Research, Institute of Physiology,University of Zurich, SwitzerlandSearch for other works by this author on:Thomas F. LüscherThomas F. LüscherCardiology, CardioVascular Center, University Hospital Zurich and Cardiovascular Research, Institute of Physiology,University of Zurich, SwitzerlandSearch for other works by this author on:
-
37 - 47: Intravascular and Extravascular Coagulation and Fibrinolysis in the Diseased LungByPhillip Markart;Phillip MarkartUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:Malgorzata Wygrecka;Malgorzata WygreckaUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:Clemens Ruppert;Clemens RuppertUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:Martina Korfei;Martina KorfeiUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:Bhola Dahal;Bhola DahalUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:Thorsten Jennes;Thorsten JennesUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:Klaus T. Preissner;Klaus T. PreissnerUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:Werner Seeger;Werner SeegerUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:Andreas GüntherAndreas GüntherUniversity of Giessen Lung Center, Giessen, GermanySearch for other works by this author on:
-
48 - 59: Interaction of Platelets and Inflammatory Endothelium in the Development and Progression of Coronary Artery DiseaseByHarald F. Langer;Harald F. LangerInternal Medicine III, Eberhard Karls University Tübingen, GermanySearch for other works by this author on:Meinrad P. GawazMeinrad P. GawazInternal Medicine III, Eberhard Karls University Tübingen, GermanySearch for other works by this author on:
-
60 - 70: Infectious Agents, the Contact System, and Innate ImmunityByInga-Maria Frick;Inga-Maria FrickDepartment of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, SwedenSearch for other works by this author on:Heiko HerwaldHeiko HerwaldDepartment of Clinical Sciences, Division of Infection Medicine, Lund University, Lund, SwedenSearch for other works by this author on:
-
71 - 88: Fibrinolysis and Host Response in Bacterial InfectionsBySimone Bergmann;Simone BergmannMax von Pettenkofer Institute, Ludwig Maximilians University Munich, GermanySearch for other works by this author on:Sven HammerschmidtSven HammerschmidtMax von Pettenkofer Institute, Ludwig Maximilians University Munich, GermanySearch for other works by this author on:
-
89 - 112: Selective Immune Apheresis Technologies – Where Do We Stand?ByWolfgang Ramlow;Wolfgang RamlowaApheresis Center, Rostock,Search for other works by this author on:Heinrich Prophet;Heinrich ProphetaApheresis Center, Rostock,Search for other works by this author on:Jörg EmmrichJörg EmmrichbDepartment of Gastroenterology, University of Rostock, GermanySearch for other works by this author on:
-
113 - 122: Cytapheresis as a Nonpharmacological Therapy for Inflammatory Bowel DiseaseByTakayuki Matsumoto;Takayuki MatsumotoDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:Ken Fukunaga;Ken FukunagaDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:Koji Kamikozuru;Koji KamikozuruDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:Katsutoshi Tozawa;Katsutoshi TozawaDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:Yoko Yokoyama;Yoko YokoyamaDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:Takeshi Kusaka;Takeshi KusakaDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:Kunio Onishi;Kunio OnishiDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:Hiroto Miwa;Hiroto MiwaDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:Shiro NakamuraShiro NakamuraDivision of Lower G-I Disease, Hyogo College of Medicine, Nishinomiya, JapanSearch for other works by this author on:
-
123 - 131: Immunoadsorption in Dilated CardiomyopathyByAlexander Staudt;Alexander StaudtDepartment of Internal Medicine B, University of Greifswald, GermanySearch for other works by this author on:Stephan B. FelixStephan B. FelixDepartment of Internal Medicine B, University of Greifswald, GermanySearch for other works by this author on:
-
132 - 150: Therapeutic Use of Circulating Peripheral Blood Stem CellsByRainer Haas;Rainer HaasClinic for Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, GermanySearch for other works by this author on:Ingmar Bruns;Ingmar BrunsClinic for Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, GermanySearch for other works by this author on:Guido Kobbe;Guido KobbeClinic for Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, GermanySearch for other works by this author on:Ralf KronenwettRalf KronenwettClinic for Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, GermanySearch for other works by this author on:
-
151 - 161: Cultured Red Blood Cells: A New Advance in Stem Cell EngineeringByLuc DouayLuc DouayINSERM, UMR_S 893 and Pierre and Marie Curie University Paris, FranceSearch for other works by this author on:
-
162 - 177: From Hematopoietic Stem Cells to Megakaryocytes and PlateletsByRémi Favier;Rémi FavieraINSERM U790,bInstitute Gustave Roussy, Villejuif,cHematological Laboratory, Hospital Armand Trousseau, Paris,Search for other works by this author on:William Vainchenker;William VainchenkeraINSERM U790,bInstitute Gustave Roussy, Villejuif,dUniversity Paris XI, U790, Villejuif, FranceSearch for other works by this author on:Hana RaslovaHana RaslovaaINSERM U790,bInstitute Gustave Roussy, Villejuif,dUniversity Paris XI, U790, Villejuif, FranceSearch for other works by this author on:
-
178 - 188: The Bloodgen Project of the European UnionByNeil D. AventNeil D. AventCentre for Research in Biomedicine, Faculty of Health and Life Sciences, University of the West of England, Bristol, UKSearch for other works by this author on:
-
189 - 198: Genotyping of Red Blood Cell, Granulocyte and Platelet Antigens: Current Applications in the German-Speaking CountriesByWilly A. Flegel;Willy A. FlegelaInstitute for Transfusion Medicine, University Hospital Ulm,bDRK Blutspendedienst Baden-Württemberg – Hessen, Institute Ulm,Search for other works by this author on:Franz F. WagnerFranz F. WagnercDRK Blutspendedienst NSTOB, Institute Springe, GermanySearch for other works by this author on:
-
199 - 208: Molecular Methods in Immunohematology: Use of the PCR-SSP TechniqueByMartina PragerMartina PragerMolecular Genetics Department, BAG Health Care GmbH, Lich, GermanySearch for other works by this author on:
-
209 - 218: Fetal Blood Group GenotypingByAxel SeltsamAxel SeltsamInstitute for Transfusion Medicine, Hannover Medical School, GermanySearch for other works by this author on:
-
219 - 233: Innate Immunity of Platelets: Specific Interactions with VirusesByClaire Flaujac;Claire FlaujacaDepartment of Hematology and Immunology, Ambroise Paré Hospital, Boulogne,bFaculty of Medicine Paris-Ile de France-Ouest, University of Versailles,cINSERM U567, Department of Hematology, Cochin Institute, Paris, FranceSearch for other works by this author on:Siham Boukour;Siham BoukourcINSERM U567, Department of Hematology, Cochin Institute, Paris, FranceSearch for other works by this author on:Elisabeth Cramer BordéElisabeth Cramer BordéaDepartment of Hematology and Immunology, Ambroise Paré Hospital, Boulogne,bFaculty of Medicine Paris-Ile de France-Ouest, University of Versailles,cINSERM U567, Department of Hematology, Cochin Institute, Paris, FranceSearch for other works by this author on:
-
234 - 247: Bacterial Contamination of Platelet Components: Prevalence and Measures to Prevent Transfusion-Transmitted Bacterial InfectionByLaurence CorashLaurence CorashMedical Affairs, Cerus Corporation, Concord, CA,Department of Laboratory Medicine, University of California, San Francisco, CA, USASearch for other works by this author on:
-
248 - 263: Clinical Experience with Pathogen Inactivation of Platelet Components for Transfusion SupportByJean-Pierre Cazenave;Jean-Pierre CazenaveaEFS-Alsace, Strasbourg,bINSERM U311, Strasbourg,cUniversity Louis Pasteur, Strasbourg, FranceSearch for other works by this author on:Jean-Pierre Raidot;Jean-Pierre RaidotaEFS-Alsace, Strasbourg,Search for other works by this author on:Marie-Louise Wiesel;Marie-Louise WieselaEFS-Alsace, Strasbourg,bINSERM U311, Strasbourg,Search for other works by this author on:Hervé IsolaHervé IsolaaEFS-Alsace, Strasbourg,bINSERM U311, Strasbourg,Search for other works by this author on:
-
264 - 273: Acute Bleeding Complications: Pathophysiology, Diagnosis and ManagementByMichael SpannaglMichael SpannaglTransfusion Medicine and Hemostasis, Munich University Hospital, Munich, GermanySearch for other works by this author on:
-
274 - 287: Challenges in Life-Threatening Hemorrhages: The Acquired HemophiliaByMarcus Stockschläder;Marcus StockschläderDepartment of Experimental and Clinical Hemostasis, Hemotherapy, and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, GermanySearch for other works by this author on:Rüdiger E. ScharfRüdiger E. ScharfDepartment of Experimental and Clinical Hemostasis, Hemotherapy, and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, GermanySearch for other works by this author on:
-
288 - 295: The Unrecognized von Willebrand Disease: A Frequent Cause of Bleeding ComplicationsByReinhard Schneppenheim;Reinhard SchneppenheimaDepartment of Pediatric Hematology and Oncology, Medical Center Hamburg-Eppendorf,Search for other works by this author on:Ulrich BuddeUlrich BuddebAescuLabor Hamburg, Laboratory for Coagulation, GermanySearch for other works by this author on:
-
296 - 316: Acquired Platelet Function Defects: An Underestimated but Frequent Cause of Bleeding Complications in Clinical PracticeByRüdiger E. ScharfRüdiger E. ScharfDepartment of Experimental and Clinical Hemostasis, Hemotherapy, and Transfusion Medicine, University Medical Center and Biological Medical Research Center, Heinrich Heine University Düsseldorf, Düsseldorf, GermanySearch for other works by this author on:
-
317 - 325: Past, Presence, and Future of Genetics in ThrombophiliaByPieter H. ReitsmaPieter H. ReitsmaEinthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, The NetherlandsSearch for other works by this author on:
-
326 - 343: Thrombophilia and Vascular Complications in PregnancyByAndrea Gerhardt;Andrea GerhardtDepartment of Experimental and Clinical Hemostasis, Hemotherapy, and Transfusion Medicine,Heinrich Heine University Medical Center, Düsseldorf, GermanySearch for other works by this author on:Rüdiger E. ScharfRüdiger E. ScharfDepartment of Experimental and Clinical Hemostasis, Hemotherapy, and Transfusion Medicine,Heinrich Heine University Medical Center, Düsseldorf, GermanySearch for other works by this author on:
-
344 - 351: Prevention and Therapy of Pregnancy-Associated Thromboembolic EventsByIngrid PabingerIngrid PabingerClinical Division of Haematology and Haemostasis, Department of Internal Medicine I,General Hospital of Vienna, Medical University of Vienna, AustriaSearch for other works by this author on:
-
352 - 362: The Potential Role of Natural Killer Cells in the Treatment of Malignant DiseaseByRupert Handgretinger;Rupert HandgretingerChildren’s University Hospital, Department of Hematology / Oncology and General Pediatrics,University of Tübingen, GermanySearch for other works by this author on:Matthias Pfeiffer;Matthias PfeifferChildren’s University Hospital, Department of Hematology / Oncology and General Pediatrics,University of Tübingen, GermanySearch for other works by this author on:Heiko-Manuel Teltschik;Heiko-Manuel TeltschikChildren’s University Hospital, Department of Hematology / Oncology and General Pediatrics,University of Tübingen, GermanySearch for other works by this author on:Tobias Feuchtinger;Tobias FeuchtingerChildren’s University Hospital, Department of Hematology / Oncology and General Pediatrics,University of Tübingen, GermanySearch for other works by this author on:Ingo Mueller;Ingo MuellerChildren’s University Hospital, Department of Hematology / Oncology and General Pediatrics,University of Tübingen, GermanySearch for other works by this author on:Peter LangPeter LangChildren’s University Hospital, Department of Hematology / Oncology and General Pediatrics,University of Tübingen, GermanySearch for other works by this author on:
-
363 - 372: Current and Future Use of Dendritic Cells for Tolerance InductionByHolger HacksteinHolger HacksteinInstitute for Clinical Immunology and Transfusion Medicine, University Hospital Giessen and Marburg,Giessen, GermanySearch for other works by this author on:
-
373 - 384: Adult and Embryonic Stem Cell TherapyByJürgen Hescheler;Jürgen HeschelerInstitute of Neurophysiology, University of Cologne, GermanySearch for other works by this author on:Dimitry SpitkovskyDimitry SpitkovskyInstitute of Neurophysiology, University of Cologne, GermanySearch for other works by this author on:
-
385 - 393: Hemostasis-Navigated Hemotherapy: Diagnosis, Management, and Monitoring of Patients with Active BleedingByBernd Pötzsch;Bernd PötzschaInstitute for Experimental Hematology and Transfusion Medicine, University Medical Center Bonn,Search for other works by this author on:Rüdiger E. ScharfRüdiger E. ScharfbDepartment of Experimental and Clinical Hemostasis, Hemotherapy, and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, GermanySearch for other works by this author on:
-
394 - 402: The Impact of Demographic Changes on Transfusion Demand and Blood Supply: Need for Systematic Blood Donor ResearchByAndreas Greinacher;Andreas GreinacheraInstitute for Immunology and Transfusion Medicine, Greifswald,Search for other works by this author on:Uwe Konerding;Uwe KonerdingbInstitute for Community Medicine, Ernst-Moritz-Arndt-University of Greifswald, GermanySearch for other works by this author on:Konstanze Fendrich;Konstanze FendrichbInstitute for Community Medicine, Ernst-Moritz-Arndt-University of Greifswald, GermanySearch for other works by this author on:Ulf Alpen;Ulf AlpenaInstitute for Immunology and Transfusion Medicine, Greifswald,Search for other works by this author on:Wolfgang HoffmannWolfgang HoffmannbInstitute for Community Medicine, Ernst-Moritz-Arndt-University of Greifswald, GermanySearch for other works by this author on:
